Novartis AG (NVS)
162.67
-1.25
(-0.76%)
USD |
NYSE |
Feb 20, 16:00
163.99
+1.32
(+0.81%)
After-Hours: 20:00
Novartis SG&A Expense (Quarterly) : 3.440B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Amgen, Inc. | 1.952B |
| AstraZeneca PLC | 152.78M |
| Gilead Sciences, Inc. | 1.794B |
| Regeneron Pharmaceuticals, Inc. | 775.00M |